Autoplaque vs Merge PACS
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Autoplaque is a specialized AI-powered software focused on quantitative analysis of coronary plaques from CT angiography images, aiding in heart attack risk prediction. In contrast, Merge PACS is an enterprise-level Picture Archiving and Communication System (PACS) that manages imaging data and integrates third-party AI applications across multi-site health systems. While both operate in the radiology and cardiology imaging domain, Autoplaque provides a specific analytical AI function, whereas Merge PACS offers the foundational infrastructure for imaging workflow and AI integration.
Choose Autoplaque if…
Choose Autoplaque if your primary need is highly specialized, AI-driven quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This workstation-based software is ideal for clinicians focused on precise heart attack risk prediction and detailed treatment guidance based on specific plaque characteristics.
View Autoplaque →Choose Merge PACS if…
Choose Merge PACS if your organization requires an enterprise-level imaging solution to streamline radiology and cardiology workflows across multi-site health systems. This system is best suited for consolidating diverse imaging data, integrating various third-party AI applications into a unified worklist, and enabling flexible, secure access for diagnostic interpretation across an entire enterprise.
View Merge PACS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Merge PACS |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | On-premise, Cloud, Hybrid |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Merge PACS |
|---|---|---|
| Primary Function | AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | Enterprise-level Picture Archiving and Communication System (PACS) that streamlines radiology workflows, consolidates imaging data, and integrates AI insights across multi-site health systems. |
| Company | Cedars-Sinai Medical Center: AIM | Merative |
| Core AI Capability | AI-powered quantitative analysis of atherosclerotic plaque; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician). | AI integration and readiness (single worklist access to 3rd party AI applications). |
| Key Analytical Output / Workflow Feature | Detection and characterization of coronary artery plaque; Measurement of luminal stenoses. | Customizable, composite worklist for multiple specialties; Enhanced diagnostic workflows. |
| Supported Specialties | Cardiology, Radiology | Cardiology, Radiology |
| Enterprise-Level Capabilities | Not specified | Enterprise-wide image management and consolidation. |
| Integration with External Systems | Not specified | Integration with EMR/EHR, RIS, HIS, and VNA systems. |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Merge PACS.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Autoplaque is an AI-powered software specifically designed for the quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. Merge PACS is an enterprise-level Picture Archiving and Communication System (PACS) that focuses on streamlining radiology workflows, consolidating imaging data, and integrating AI insights across multi-site health systems.
Autoplaque is an AI-powered software that performs automated quantitative analysis of atherosclerotic plaque, including detection, characterization, and measurement of luminal stenoses. Merge PACS is 'AI ready' and facilitates AI integration by providing single worklist access to third-party AI applications and algorithms.
Merge PACS is designed for enterprise-wide image management and consolidation, with explicit integration capabilities for EMR/EHR, RIS, HIS, and VNA systems. Autoplaque is described as a workstation-based post-processing application, and its integration with broader IT systems like EMR/EHR is not specified in the provided information.
Merge PACS is HIPAA compliant and implies a Business Associate Agreement (BAA), with the vendor advising to contact them for specific BAA details. Autoplaque does not specify its HIPAA compliance or BAA status in the provided information.
Autoplaque directly addresses the need for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images to aid in heart attack risk prediction and treatment guidance. Merge PACS focuses on enhancing diagnostic workflows across multiple modalities and specialties, consolidating imaging data, and providing real-time analytics for improved operational efficiency in radiology and cardiology.